|
Global pharma co-packing on the rise
The global pharmaceutical contract manufacturing and contract research organizations revenue reached at $196.5 billion in 2010, set to top $217.9 billion in 2011, according to BCC Research, Wellesley, Mass. This is projected to reach $360.6 billion by 2016, increasing at a compound annual growth rate (CAGR ) of 10.6 %. Additional highlights, from various studies released in recent weeks, follow:
North American markets' revenue for bulk drugs in contract manufacturing in 2009 was about $8.8 billion and increased to about $9.7 billion in 2010. This is projected to reach $16.6 billion by 2016 for a 5 -year CAGR of 9.4%.
The European contract manufacturing market for OTC and nutritional products was valued at about $46.0 billion in 2010, and is estimated at $51.3 in 2011. This will further grow to $86.5 billion by 2016 at a CAGR of 11%.
BCC also studied Emerging and "Rest of World" markets, which had revenue of approximately $10.5 billion in 2010, with an increase to $11.2 billion in 2011 in the bulk drugs/API market. The revenue of this market is expected to rise to $15.5 billion in 2016, with the CAGR expected to rise at 6.7%.
BCC aggregates its research publications for pharmaceuticals here.
PGP announces kosher, organic & GMP certs
PGP International, Woodland, Calif., announced that its contract packaging facility in Springfield, Mo., has obtained kosher certification from the Orthodox Union; organic certification from the Minnesota Crop Improvement Association and also recently was certified as complying with GMPs (good manufacturing practices ) by NSF International. The 52,000 -square -foot Springfield plant specializes in formulating sports nutrition and powdered food products. Capabilities include formulation, ingredient sourcing, blending, processing, labeling and packaging, according to Bishop, contract packaging manager.
Does the FDA understand co-packing?
Our media sibling, Healthcare Packaging, asked its readers — healthcare and pharmaceutical packaging professionals — to choose from among 21 separate topics to reveal their Top 10 areas of concern for 2012. Leading the list, based on the number of responses, was processing and packaging, followed by package testing, FDA and regulatory issues and new developments and materials. Contract packaging was ninth, but still a Top 10 concern.
On contract packaging, open -ended comments suggested that the U.S. FDA "doesn't fully understand the contract packager. Clearer requirements by the FDA regarding packaging and more emphasis on contract packaging were two solutions proposed," according to a summary write-up of the survey: "Healthcare Packaging Professionals Reveal Top Ten Areas of Concern in 2012".
Fall Workshop reminder
Don't hit that snooze button — it's almost time: The Contract Packaging Association's Fall Workshop, November 7 and 8 in Chicago. For more, visit the Workshop homepage or call the CPA at 630-544-5053.
|
